PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2012 2013 2014 2015 2016
The purpose of COAG with the Barbados Ministry of Health (MOH) is to strengthen capacity to expand coordinated SI and laboratory programs. The SI component strengthens systems for HIV/AIDS and TB case-based reporting, M&E, and implementation of high quality MARPS surveys (MSM, CSW). Laboratory training and procurement and maintenance of laboratory equipment are supported along with implementation of the laboratory management framework for accreditation and to ensure continuous testing and release of quality results. To assure a cadre of well trained clinical laboratory personnel, both new and in-service laboratory personnel will be trained to support key testing and quality essential components including: quality assurance practices, a laboratory quality management system, accreditation, clinical laboratory practices, and laboratory safety. Activities support sustainability and staff retention.This IM supports the USG Caribbean Regional Partnership Framework Goals for Strategic Information (Goal 2), and Laboratory Support (Goal 3). CDC will work in close collaboration with the MOH to ensure efficient use of USG resources in achieving programmatic priorities and in delivering results more cost effectively. The MOH will develop an annual work plan with agreed-upon performance benchmarks and with a plan for sustainability local ownership. The MOH will be required to report on progress towards the essential and additional outcome indicators on a semi-annual and annual basis via SAPR reporting.
The Barbados Ministry of Health will utilize the cooperative agreement funds to support the capacity building of laboratory staff through regional and international trainings. Training workshop content areas will be: 1) TB diagnosis and EQA for AFB smear microscopy; 2) Good Clinical Laboratory practices (GCLP); 3) HIV rapid testing (including algorithm development, quality testing and use of logbooks); 4) and other areas of wet laboratory training.
Furthermore, selected laboratory staff will be sent to the International Laboratory Branch at CDC Atlanta to be trained on the use of both manual and automated Roche Amplicor methods for early infant HIV diagnosis (EID) to support PMTCT programs within the region. Other international trainings involving lab staff from these countries will include advanced trainings in CD4, clinical chemistry, hematology, Bio-safety and laboratory management as they prepare for accreditation.
These activities will greatly enhance and support the current cross cutting goal of training, capacity building and ensuring long term sustainability of in-country systems for testing, diagnosis, and patient monitoring.New/continuing activity: Continuing activity
The focus of this implementing mechanism will be: 1) To strengthen the GOB capacity to coordinate and implement strategic information activities for HIV/AIDS including HIV case reporting, behavioral and biological surveillance among vulnerable groups (MSM and CSW), program and intervention reporting and monitoring and analysis/use of data for program improvement. 2) Use surveillance data for decision making and program planning.
CDC GAP and CRO technical advisors will work in close collaboration with the MOH to ensure progress towards the goals and objectives of the three-year Cooperative Agreement. Joint reviews, site visits, and observation of selected activities under the Co-Ag will be core components of a supportive supervision and quality assurance strategy for this implementing mechanism.
Indicator targets related to the HSVI budget code for this cooperative agreement include the existence of high quality surveillance and program monitoring reports for the preceding year, and number of countries completing special studies.
This implementing mechanism supports the USG Caribbean Regional Partnership Framework Goals for Strategic Information (Goal 2), and Laboratory Support (Goal 3).This Cooperative Agreement will contribute to strengthening the health systems in Barbados, adding value to the delivery of laboratory services, and integrating high quality HIV/AIDS data with the collection and reporting of surveillance and program monitoring data within the wider health sector.
